0001209191-23-054018.txt : 20231101 0001209191-23-054018.hdr.sgml : 20231101 20231101161252 ACCESSION NUMBER: 0001209191-23-054018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231030 FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crockett Thomas Andrew CENTRAL INDEX KEY: 0001690920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36830 FILM NUMBER: 231368401 MAIL ADDRESS: STREET 1: BUILDING 227, TETRICUS SCIENCE PARK STREET 2: PORTON DOWN, SALISBURY CITY: WILTSHIRE STATE: X0 ZIP: SP4 0JQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200915291 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 901E CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 999-0075 MAIL ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 901E CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Therapeutics, Inc. DATE OF NAME CHANGE: 20140916 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery, Inc DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery Inc DATE OF NAME CHANGE: 20060105 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-30 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001690920 Crockett Thomas Andrew C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142 1 1 0 0 CEO 0 Common Stock 2023-10-30 4 G 0 8000 0.00 D 138756 D /s/ Benjamin L. Palleiko, Attorney-in-Fact 2023-11-01